Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics
L Chitsike, P Duerksen-Hughes - Virology Journal, 2021 - Springer
The COVID-19 pandemic has put healthcare infrastructures and our social and economic
lives under unprecedented strain. Effective solutions are needed to end the pandemic while …
lives under unprecedented strain. Effective solutions are needed to end the pandemic while …
Nano-antivirals: A comprehensive review
Nanoparticles can be used as inhibitory agents against various microorganisms, including
bacteria, algae, archaea, fungi, and a huge class of viruses. The mechanism of action …
bacteria, algae, archaea, fungi, and a huge class of viruses. The mechanism of action …
Lessons learned: new insights on the role of cytokines in COVID-19
M Buszko, A Nita-Lazar, JH Park, PL Schwartzberg… - Nature …, 2021 - nature.com
In the midst of resurging COVID-19 cases, the second NIH/FDA virtual COVID-19 and
Cytokines symposium was held on 1 December 2020, focusing on longitudinal studies of …
Cytokines symposium was held on 1 December 2020, focusing on longitudinal studies of …
Efficacy of telemedicine and telemonitoring in at-home monitoring of patients with COVID-19
E Casariego-Vales, R Blanco-Lopez… - Journal of clinical …, 2021 - mdpi.com
Aim: this work aims to assess if telemedicine and telemonitoring are clinically useful and
safe for at-home monitoring of Coronavirus disease 2019 (COVID-19) patients. Methods …
safe for at-home monitoring of Coronavirus disease 2019 (COVID-19) patients. Methods …
The use of tocilizumab in patients with COVID-19: a systematic review, meta-analysis and trial sequential analysis of randomized controlled studies
Background: Among the several therapeutic options assessed for the treatment of
coronavirus disease 2019 (COVID-19), tocilizumab (TCZ), an antagonist of the interleukine …
coronavirus disease 2019 (COVID-19), tocilizumab (TCZ), an antagonist of the interleukine …
Use of antivirals in SARS-CoV-2 infection. Critical review of the role of remdesivir
The aim of this report is to review the literature and shed light on the uncertainties
surrounding the use of antiviral agents in general and remdesivir in COVID-19 patients. This …
surrounding the use of antiviral agents in general and remdesivir in COVID-19 patients. This …
Progress and pitfalls of a year of drug repurposing screens against COVID-19
J Sourimant, M Aggarwal, RK Plemper - Current Opinion in Virology, 2021 - Elsevier
Near the end of 2019, a new betacoronavirus started to efficiently transmit between humans,
resulting in the current COVID-19 pandemic. Unprecedented worldwide efforts were made to …
resulting in the current COVID-19 pandemic. Unprecedented worldwide efforts were made to …
Peptide binder with high-affinity for the SARS-CoV-2 spike receptor-binding domain
Rapid antigen detection tests are urgently needed for the early diagnosis of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). The discovery of a binder with high …
respiratory syndrome coronavirus 2 (SARS-CoV-2). The discovery of a binder with high …
[HTML][HTML] Early alveolar epithelial cell necrosis is a potential driver of COVID-19-induced acute respiratory distress syndrome
Acute respiratory distress syndrome (ARDS) with COVID-19 is aggravated by
hyperinflammatory responses even after the peak of the viral load has passed; however, its …
hyperinflammatory responses even after the peak of the viral load has passed; however, its …
[HTML][HTML] Aspectos básicos de la COVID-19 para el manejo desde atención primaria
JM Molero-García, J Arranz-Izquierdo… - Atención primaria, 2021 - Elsevier
El SARS-CoV-2 se transmite de persona a persona por inhalación o por el contacto con
gotas y aerosoles respiratorios. El período de incubación mediano es 5, 1 días. Fiebre, tos …
gotas y aerosoles respiratorios. El período de incubación mediano es 5, 1 días. Fiebre, tos …